Bislett Management LLC Increases Holdings in Amrize Ltd $AMRZ

Bislett Management LLC boosted its position in Amrize Ltd (NYSE:AMRZFree Report) by 20.0% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 60,000 shares of the company’s stock after buying an additional 10,000 shares during the period. Amrize makes up approximately 2.1% of Bislett Management LLC’s investment portfolio, making the stock its 14th largest holding. Bislett Management LLC’s holdings in Amrize were worth $2,912,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently bought and sold shares of AMRZ. Vanguard Group Inc. lifted its position in Amrize by 41.0% during the third quarter. Vanguard Group Inc. now owns 30,094,083 shares of the company’s stock valued at $1,468,460,000 after purchasing an additional 8,743,543 shares during the period. Norges Bank acquired a new position in shares of Amrize in the 2nd quarter valued at about $670,915,000. Dodge & Cox purchased a new stake in shares of Amrize in the second quarter worth about $622,085,000. JPMorgan Chase & Co. purchased a new stake in shares of Amrize in the second quarter worth about $220,404,000. Finally, Allspring Global Investments Holdings LLC grew its holdings in Amrize by 247.0% during the third quarter. Allspring Global Investments Holdings LLC now owns 4,386,926 shares of the company’s stock worth $212,449,000 after acquiring an additional 3,122,716 shares during the period.

More Amrize News

Here are the key news stories impacting Amrize this week:

  • Positive Sentiment: CEO Jan Philipp Jenisch bought 60,000 shares (~$3.48M at ~$58.05), a meaningful insider purchase that signals confidence from the top. CEO Purchase Filing
  • Positive Sentiment: Other senior insiders increased positions: CFO Ian Johnston (4,250 sh.), CTO Roald Brouwer (3,000 sh.) and director/insider Jaime Hill (multiple purchases totaling several thousand shares). Collective insider accumulation reinforces management confidence. Insider Filings
  • Positive Sentiment: Analyst upgrades/price-target lifts (Oppenheimer, Truist, Berenberg, Citi among others) have pushed consensus to a “Moderate Buy” with an average target near $64, supporting positive medium-term sentiment. Analyst Coverage Summary
  • Neutral Sentiment: Short interest fell ~19.6% in late February to ~8.04M shares (≈1.5% of float), lowering short-pressure but also reducing potential for a short squeeze — mixed implications for near-term volatility.
  • Neutral Sentiment: Small institutional position changes reported in Q4 (several funds added modest stakes); nothing indicating large-scale reallocations. Institutional Holdings
  • Negative Sentiment: Q4 results: EPS beat ($0.62 vs. $0.59 est.) but revenue missed (~$2.84B vs. $2.95B est.) and revenue was down ~0.4% year-over-year — this top-line weakness is the primary near-term negative catalyst pressuring the stock. Earnings Call Highlights

Wall Street Analyst Weigh In

AMRZ has been the topic of several recent research reports. UBS Group upped their price objective on Amrize from $53.00 to $57.00 and gave the stock a “neutral” rating in a research report on Thursday, January 8th. Bank of America set a $58.00 target price on shares of Amrize in a research note on Monday, January 12th. Wall Street Zen raised shares of Amrize from a “sell” rating to a “hold” rating in a report on Sunday, March 1st. Citigroup raised their price target on shares of Amrize from $63.00 to $67.00 and gave the company a “buy” rating in a research report on Thursday, January 8th. Finally, Oppenheimer reaffirmed an “outperform” rating and issued a $70.00 price objective (up from $64.00) on shares of Amrize in a report on Thursday, February 19th. One research analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating and seven have issued a Hold rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $64.14.

Read Our Latest Report on AMRZ

Amrize Stock Down 1.7%

AMRZ stock opened at $58.18 on Thursday. The stock has a market capitalization of $32.18 billion and a P/E ratio of 23.65. The firm has a 50-day simple moving average of $57.88 and a 200-day simple moving average of $53.62. The company has a quick ratio of 1.10, a current ratio of 1.64 and a debt-to-equity ratio of 0.37. Amrize Ltd has a 52 week low of $44.12 and a 52 week high of $65.94.

Amrize (NYSE:AMRZGet Free Report) last issued its quarterly earnings results on Tuesday, February 17th. The company reported $0.62 earnings per share for the quarter, beating analysts’ consensus estimates of $0.59 by $0.03. The company had revenue of $2.84 billion during the quarter, compared to analysts’ expectations of $2.95 billion. The firm’s revenue was down .4% on a year-over-year basis.

Insider Transactions at Amrize

In other news, CEO Jan Philipp Jenisch purchased 60,000 shares of the company’s stock in a transaction that occurred on Friday, March 6th. The stock was purchased at an average cost of $58.05 per share, for a total transaction of $3,483,000.00. Following the completion of the transaction, the chief executive officer owned 1,703,582 shares of the company’s stock, valued at $98,892,935.10. This trade represents a 3.65% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Jaime Hill acquired 3,184 shares of Amrize stock in a transaction that occurred on Monday, March 9th. The stock was purchased at an average cost of $56.34 per share, with a total value of $179,386.56. Following the completion of the purchase, the insider owned 26,000 shares in the company, valued at $1,464,840. The trade was a 13.96% increase in their position. The SEC filing for this purchase provides additional information. Insiders acquired 72,634 shares of company stock worth $4,224,656 over the last three months.

Amrize Company Profile

(Free Report)

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.

See Also

Want to see what other hedge funds are holding AMRZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amrize Ltd (NYSE:AMRZFree Report).

Institutional Ownership by Quarter for Amrize (NYSE:AMRZ)

Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.